Halozyme Therapeutics
HALO
#2469
Rank
โ‚น493.20 B
Marketcap
โ‚น3,877
Share price
-14.90%
Change (1 day)
15.95%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น56.24 Billion

According to Halozyme Therapeutics's latest financial reports the company has โ‚น56.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น27.97 B-6.83%
2022-12-31โ‚น30.02 B-45.56%
2021-12-31โ‚น55.14 B104.9%
2020-12-31โ‚น26.91 B-10.41%
2019-12-31โ‚น30.04 B21.18%
2018-12-31โ‚น24.78 B-17.26%
2017-12-31โ‚น29.95 B115.08%
2016-12-31โ‚น13.92 B93.47%
2015-12-31โ‚น7.19 B-16.24%
2014-12-31โ‚น8.59 B94.58%
2013-12-31โ‚น4.41 B-18.92%
2012-12-31โ‚น5.44 B94.96%
2011-12-31โ‚น2.79 B-25.1%
2010-12-31โ‚น3.73 B19.18%
2009-12-31โ‚น3.13 B2.22%
2008-12-31โ‚น3.06 B-20.11%
2007-12-31โ‚น3.83 B95.87%
2006-12-31โ‚น1.95 B127.32%
2005-12-31โ‚น0.86 B24.19%
2004-12-31โ‚น0.69 B2923.65%
2003-12-31โ‚น22.92 M391.64%
2002-12-31โ‚น4.66 M269.93%
2001-12-31โ‚น1.26 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น20.91 B-62.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น297.02 B 428.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น176.85 B 214.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น840.14 B 1,393.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น614.92 B 993.21%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.713 T 2,946.20%๐Ÿ‡บ๐Ÿ‡ธ USA